BS

Bhuneshvari Sahu

Active Director Director DIN 09365287
DIN 09365287 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Bhuneshvari Sahu

Data last updated:

Bhuneshvari Sahu is a Director at Stabo Life Private Limited (since 2021). The company operates in Pharma. Stabo Life Private Limited reported revenue of ₹2.2 Lakh (FY 2025).

DIN 09365287
Primary Designation Director
Industry Pharma
First Appointment 20 Oct 2021
Oldest Company Age 5 yrs
Largest company Stabo Life Private Limited · ₹2.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stabo Life Private Limited U24290MH2021PTC369692
Director20 Oct 20212021₹2.2 Lakh (FY 2025)Active

Board colleagues of Bhuneshvari Sahu

NameDINCompanyDesignation
Tajesh Kumar Sahu07815103Stabo Life Private LimitedDirector

Directorship timeline

Open interactive timeline →
Stabo Life Private Limited
Premium access

Shareholding and investment profile for Bhuneshvari Sahu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhuneshvari Sahu

Bhuneshvari Sahu currently holds 1 directorship: Stabo Life Private Limited (Director, since 20 Oct 2021, revenue ₹2.2 Lakh (FY 2025)).

Bhuneshvari Sahu was first appointed on 20 Oct 2021 as Director at Stabo Life Private Limited.

The current boards of Bhuneshvari Sahu's companies include Tajesh Kumar Sahu (Stabo Life Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available